-
Mashup Score: 0Complex Autoantibody Patterns in RA | RheumNow - 44 minute(s) ago
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity of these antibodies using powerful lab tools capable of analysing our immune system at molecular levels. This discovery reported in Nature Communicationssuggests that current assumptions about the origin of RA are too simple. Still, their findings may point towards improved diagnostics.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3ACR/APLAR Research Exchange Program - 44 minute(s) ago
The ACR/APLAR Research Exchange Program promotes the international exchange of clinical and research skills, expertise and knowledge within rheumatology.
Source: rheumatology.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0Homepage | Lupus Science & Medicine - 2 hour(s) ago
A lupus journal publishing basic, clinical, translational and epidemiological studies on all aspects of lupus and related diseases. An official journal of Lupus Foundation of America.
Source: lupus.bmj.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
Objective To investigate gout flare rates based on repeated serum urate (SU) measurements in a randomised controlled trial of urate-lowering therapy (ULT), accounting for dropout and death. Methods We performed a secondary analysis using data from Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout, which randomised participants to febuxostat or allopurinol, titrated to target SU <6 mg/dL with flare prophylaxis for 6 months. SU was categorised as ≤3.9, 4.0–5.9, 6.0–7.9, 8.0–9.9 or ≥ 10 mg/dL at each 3–6 month follow-up. The primary outcome was gout flare. Poisson regression models, adjusted for covariates and factors related to participant retention versus dropout, estimated gout flare incidence rate ratios by time-varying SU category. Results Among 6183 participants, the median age was 65 years and 84% were male. Peak gout flare rates for all SU categories were observed in months 0–6, coinciding with the initiation of ULT and months 6–12 after stopping prophylaxis
Source: ard.bmj.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2Congress of Clinical Rheumatology Annual Meeting - 2 hour(s) ago
The latest news from the CCR annual meetings, and the accompanying North American Young Rheumatology Investigator Forum, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2Purpose of urate-lowering therapy 'needs to be reinforced every time patients come in' - 3 hour(s) ago
DESTIN, Fla. — Patients with gout should be continually reminded that urate-lowering therapy may go on for the rest of their life, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.“This needs to be reinforced, and it needs to be reinforced every time patients come in,” N. Lawrence Edwards, MD, MACP, MACR, a professor of medicine at the
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4Congress of Clinical Rheumatology Annual Meeting - 3 hour(s) ago
The latest news from the CCR annual meetings, and the accompanying North American Young Rheumatology Investigator Forum, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
When and how would primary care physicians (PCPs) like to hear from orthopaedic surgeons regarding mutual patients? Dr. Matt Schmitz discusses a new study that explores that question.
Source: orthobuzz.jbjs.orgCategories: General Medicine News, RheumatologyTweet-
When and how would primary care physicians (PCPs) like to hear from orthopaedic surgeons regarding mutual patients? In today's #OrthoBuzz, #JBJS Deputy Editor for Social Media Matt Schmitz discusses a new study that explores that question. https://t.co/QFfnERY9zY #ortho #PCPs https://t.co/cmrHJkAqEQ
-
-
Mashup Score: 67How to make exercise changes stick using behavioural change theory with Dr Tim Anstiss. EP#550 | BJSM Podcast - 4 hour(s) ago
Behaviour change theory and Motivational Interviewing (MI) principles are often an area cited by healthcare professionals as something they would like more training on. The BJSM has collaborated with the PACC programme to develop this podcast and has invited Dr Tim Anstiss, an expert in this area, to explain some key behaviour change theory and motivational interviewing concepts in this conversation. Tim is a medical doctor specialising in behaviour change and wellbeing improvement. He trained as a trainer in motivational interviewing in the mid 90’s and has trained thousands of health and care professionals, managers and coaches in Motivational Interviewing, health coaching, brief interventions and shared decision making. “The Physical Activity Clinical Champions or PACC programme is a national project delivering physical activity education to professionals working in healthcare to help get patients more physically active. It was previously being led by public health England as part o
Source: bjsmbmj.podbean.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4Congress of Clinical Rheumatology Annual Meeting - 4 hour(s) ago
The latest news from the CCR annual meetings, and the accompanying North American Young Rheumatology Investigator Forum, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
Complex Autoantibody Patterns in RA https://t.co/CHzUOUM2xD https://t.co/4fE7iLMwxM